Showing results (61-70 of 131) with videos related to

Sort By:
Pageof 14
Seminars in Radiation Oncology|November 28, 2020
Radiopharmaceuticals for Bone MetastasesAndrew W Smith, Benjamin A Greenberger, Robert B Den, et al.
International Journal of Radiation Oncology, Biology, Physics|October 17, 2008
There is no correlation between erectile dysfunction and dose to penile bulb and neurovascular bundles following real-time low-dose-rate prostate brachytherapyAmy N Solan, Jamie A Cesaretti, Nelson N Stone, et al.
Brachytherapy|August 9, 2020
I-125 or Pd-103 for brachytherapy boost in men with high-risk prostate cancer: A comparison of survival and morbidity outcomesNelson N Stone, Vassilios M Skouteris, Barry S Rosenstein, et al.
Brachytherapy|April 20, 2004
Prostate gland motion and deformation caused by needle placement during brachytherapyNelson N Stone, Jiten Roy, Suzanne Hong, et al.
BJUI Compass|February 17, 2025
Method to determine the nadir PSA following partial gland ablationNelson N Stone, Vassilios Skouteris, Rendi Shu, et al.
The Journal of Urology|December 17, 2009
Impact of hormonal therapy on intermediate risk prostate cancer treated with combination brachytherapy and external beam irradiationRichard G Stock, Swati Yalamanchi, Swati Yamalachi, et al.
Brachytherapy|April 6, 2004
Comparison of intraoperative dosimetric implant representation with postimplant dosimetry in patients receiving prostate brachytherapyNelson N Stone, Suzanne Hong, Yeh-Chi Lo, et al.
The Journal of Urology|May 15, 2013
Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parametersStephen Mock, Michael Leapman, Richard G Stock, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2020
Salvage low dose rate brachytherapy for prostate cancer recurrence following definitive external beam radiation therapyWilliam H Smith, Jamie Cesaretti, Chih Peng Chin, et al.
Brachytherapy|November 26, 2010
Outcomes for patients with extraprostatic prostate cancer treated with trimodality therapy, including brachytherapy, external beam radiotherapy, and hormone therapyTodd J Carpenter, Kevin Forsythe, Johnny Kao, et al.
Pageof 14